{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"11"},{"groupId":"OG001","value":"14"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"11"},{"groupId":"OG001","value":"15"}],"units":"Participants"}],"description":"To evaluate the overall response rate of participants by MYD88 L265P and CXCR4-WHIM mutations in WM. Overall response is defined as achieving at least a minor response, or \\>25% reduction in serum IgM from baseline.","groups":[{"description":"Participants who were MYD88 mutated and did not have the CXCR4 mutation","id":"OG000","title":"MYD88 Mutated, CXCR4 Wild-type"},{"description":"Participants with both the MYD88 mutation and a CXCR4 mutation","id":"OG001","title":"MYD88 Mutated, CXCR4 Mutated"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Number of participants who achieved a response by mutational status","reportingStatus":"POSTED","timeFrame":"2 Years","title":"Overall Response Rate by MYD88 L265P and CXCR4-WHIM Status","type":"SECONDARY","unitOfMeasure":"Participants"}